Joan Joo Ching Khoo (Joan Khoo)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 6

Top Topics

Benign Prostatic Hyperplasia

Roux En Y Gastric Bypass

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Diabetes, obesity & metabolism

Case reports in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Ying Tse Tan, Jiaqing Xiong, Troy Hai Kiat Puar, Joan Joo Ching Khoo, Andy Jun-Wei Wong, Shui Boon Soh
Acute Flaccid Tetraparesis after COVID-19 Infection: Think of the Thyroid. Case reports in medicine 2022 (2022)
Wanling Zeng, Joan Joo Ching Khoo
Challenging Case of Ectopic ACTH Secretion from Prostate Adenocarcinoma. Case reports in endocrinology 2022 (2022)
Joan Joo Ching Khoo, Christoph E Hagemeyer, Darren C Henstridge, Sumukh Kumble, Ting-Yi Wang, Rong Xu, Linsey Gani, Thomas King, Shui-Boon Soh, Troy Puar, Vanessa Au, Eberta Tan, Tunn-Lin Tay, Carmen Kam, Eng-Kiong Teo
Effects of water stably-enriched with oxygen as a novel method of tissue oxygenation on mitochondrial function, and as adjuvant therapy for type 2 diabetes in a randomized placebo-controlled trial. PloS one 16 (7) (2021)
Min-On Tan, Troy Hai Kiat Puar, Saravana Kumar Swaminathan, Yu-Kwang Donovan Tay, Tar-Choon Aw, David Yurui Lim, Haiyuan Shi, Lily Mae Quevedo Dacay, Meifen Zhang, Joan Joo Ching Khoo, Keng Sin Ng
Improved adrenal vein sampling from a dedicated programme: experience of a low-volume single centre in Singapore. Singapore medical journal (2020)
Joan Joo Ching Khoo, John C Hsiang, Ranu Taneja, Seok-Hwee Koo, Gaik-Hong Soon, Carmen J Kam, Ngai-Moh Law, Tiing-Leong Ang
Randomized trial comparing effects of weight loss by liraglutide with lifestyle modification in non-alcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 39 (5) (2019)
Joan Joo Ching Khoo, John Hsiang, Ranu Taneja, Ngai-Moh Law, Tiing-Leong Ang
Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. Diabetes, obesity & metabolism 19 (12) (2017)